V2 Financial group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
V2 Financial group's PFE Position: Q1 2026 in Review
V2 Financial group reduced its Pfizer (PFE) stake by 13% in Q1 2026, selling an estimated $111K and leaving 29,212 shares worth $820K. The position accounts for 0.38% of the portfolio, ranked #44.
V2 Financial group first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $3.31M in Q4 2021. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- V2 Financial group held 29,212 shares of Pfizer worth $820K as of Q1 2026.
- V2 Financial group sold 4,177 Pfizer shares in Q1 2026, an estimated $111K.
- Pfizer made up 0.38% of V2 Financial group's portfolio in Q1 2026, its #44 holding.
- V2 Financial group first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
- V2 Financial group's Pfizer position peaked at $3.31M in Q4 2021.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on V2 Financial group's 13F filing for Q1 2026, filed 4 May 2026.